GlassScriptPhysician profile
Julie May
NPI 1407048119
$5,355.07
in general payments reported to CMS, 2019-2025
34 companies · $925 in 2025
The $925 reported for 2025 was more than what 96% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $465 · 2022: $607 · 2023: $2,247 · 2024: $1,112 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,324 · Travel and Lodging: $959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,323.98 |
| Travel and Lodging | $959.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,604.44 | 2021-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $1,113.18 | 2021-2025 | Fintepla, Briviact, Nayzilam |
| Neurelis, INC. | $439.31 | 2021-2025 | Valtoco |
| Jazz Pharmaceuticals INC. | $366.47 | 2022-2025 | |
| Immedica Pharma US, INC. | $235.22 | 2022-2024 | |
| Catalyst Pharmaceuticals, INC. | $199.20 | 2023-2025 | Fycompa |
| Eisai INC. | $180.13 | 2021-2023 | |
| Acadia Pharmaceuticals INC | $171.05 | 2023-2025 | Daybue |
| Xeris Pharmaceuticals, INC. | $129.16 | 2022-2024 | Gvoke Hypopen |
| Servier Pharmaceuticals LLC | $110.42 | 2024 | |
| Supernus Pharmaceuticals, INC. | $95.72 | 2021-2023 | Qelbree |
| Sk Life Science, INC. | $88.58 | 2024-2025 | |
| Biomarin Pharmaceutical INC. | $66.18 | 2022-2024 | Voxzogo 1.2mg |
| Regeneron Healthcare Solutions, INC. | $53.16 | 2023-2024 | Dupixent |
| Tolmar, INC. | $46.91 | 2023-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aquestive Therapeutics, INC. | $45.27 | 2021-2022 | |
| Biogen, INC. | $39.54 | 2024-2025 | Skyclarys |
| Upsher-Smith Laboratories LLC | $38.17 | 2021-2025 | |
| Ns Pharma, INC. | $31.05 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $28.84 | 2021 | |
| Eton Pharmaceuticals, INC. | $25.06 | 2023 | Alkindi |
| Amneal Pharmaceuticals LLC | $23.37 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $23.18 | 2025 | Ajovy |
| Tandem Diabetes Care, INC. | $22.70 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $22.02 | 2023 | Sogroya |
| Alexion Pharmaceuticals, INC. | $21.07 | 2022 | |
| Genentech USA, INC. | $19.50 | 2025 | Evrysdi |
| Tolmar Pharmaceuticals, INC. | $19.00 | 2022 | |
| Abbott Laboratories | $17.93 | 2024 | Freestyle Libre 3 |
| Abbvie INC. | $17.68 | 2025 | |
| Nestle Healthcare Nutrition INC. | $17.46 | 2023 | |
| Genzyme Corporation | $17.32 | 2021 | |
| Lilly USA, LLC | $14.90 | 2023 | Baqsimi |
| Tris Pharma INC | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.